Clinical Trial: Clinicopathological features and outcomes of hematopoietic stem cell transplantation for monomorphic epitheliotropic intestinal T-cell lymphoma: a systematic review (Japan)

Tokyo, June 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061968) titled 'Clinicopathological features and outcomes of hematopoietic stem cell transplantation for monomorphic epitheliotropic intestinal T-cell lymphoma: a systematic review' on June 23.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Jichi Medical University Hospital

Condition: Condition - Cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To systematically clarify the clinicopathological features and outcomes of autologous and allogeneic hematopoietic stem cell transplantation in monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL)/type II enteropathy-associated T-cell lymphoma, with particular attention to reassessing published cases and studies for compatibility with contemporary diagnostic criteria for MEITL. Basic objectives2 - Safety,Efficacy

Eligibility: Age-lower limit - 16 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1. Studies or case reports involving MEITL, type II enteropathy-associated T-cell lymphoma (type II EATL), or intestinal T-cell lymphomas considered compatible with these entities. 2. Reports describing autologous or allogeneic hematopoietic stem cell transplantation. 3. Case reports, case series, retrospective studies, and prospective studies will be eligible. 4. If a study includes other diseases, only reports in which data specific to MEITL/type II EATL can be extracted will be included. 5. No restrictions will be applied with respect to race, country of origin, publication date, or language. Key exclusion criteria - 1. Duplicate publications 2. Conference abstracts only 3. Reports exclusively involving classical EATL/type I EATL 4. Reports with insufficient pathological or clinical information to support compatibility with contemporary MEITL

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 06 Month 23 Day Anticipated trial start date - 2026 Year 06 Month 25 Day Last follow-up date - 2027 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070912

Disclaimer: Curated by HT Syndication.